Annex Advisory Services LLC Purchases 3,662 Shares of Stryker Co. (NYSE:SYK)

Annex Advisory Services LLC grew its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 27.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,211 shares of the medical technology company's stock after purchasing an additional 3,662 shares during the period. Annex Advisory Services LLC's holdings in Stryker were worth $6,407,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Capital & Planning LLC raised its holdings in shares of Stryker by 3.6% in the 4th quarter. Capital & Planning LLC now owns 841 shares of the medical technology company's stock worth $304,000 after acquiring an additional 29 shares during the last quarter. Brighton Jones LLC raised its holdings in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock worth $1,643,000 after acquiring an additional 609 shares during the last quarter. U.S. Capital Wealth Advisors LLC raised its holdings in shares of Stryker by 1.4% in the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 3,572 shares of the medical technology company's stock worth $1,286,000 after acquiring an additional 51 shares during the last quarter. Optas LLC raised its holdings in shares of Stryker by 9.1% in the 4th quarter. Optas LLC now owns 815 shares of the medical technology company's stock worth $293,000 after acquiring an additional 68 shares during the last quarter. Finally, Trust Point Inc. raised its holdings in shares of Stryker by 7.7% in the 4th quarter. Trust Point Inc. now owns 1,885 shares of the medical technology company's stock worth $679,000 after acquiring an additional 134 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now directly owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 5.90% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on SYK shares. Citigroup reissued a "buy" rating and set a $455.00 target price (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. BTIG Research set a $403.00 price target on shares of Stryker and gave the stock a "buy" rating in a research note on Monday, April 14th. Evercore ISI decreased their price target on shares of Stryker from $400.00 to $390.00 and set an "outperform" rating for the company in a research note on Friday, May 2nd. Truist Financial lifted their price objective on shares of Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a research note on Monday, May 5th. Finally, The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a report on Tuesday, March 4th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Price Performance

Shares of SYK stock traded up $0.19 on Thursday, hitting $382.74. 904,802 shares of the stock traded hands, compared to its average volume of 1,332,627. The firm has a market cap of $146.09 billion, a price-to-earnings ratio of 49.32, a PEG ratio of 2.93 and a beta of 0.93. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The firm has a 50 day simple moving average of $369.68 and a two-hundred day simple moving average of $376.11. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The company's revenue was up 11.9% on a year-over-year basis. During the same period last year, the firm earned $2.50 EPS. As a group, equities research analysts predict that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.88%. Stryker's payout ratio is 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.